Cargando…
The (99m)Tc-MIP-1404 PSMA Uptake in the Isolated Paratracheal Lymph Node From the Prostate Adenocarcinoma
The oncologist consulted a 56-year-old man after receiving prostate-specific antigen screening results. Prostate-specific antigen level during the screen time was 33 ng/mL. As a result, poorly differentiated prostate adenocarcinoma with a Gleason score of 9 (5 + 4) was diagnosed. SPECT/CT scan with...
Autores principales: | Jonusas, Justinas, Tiskevicius, Sigitas, Janulionis, Ernestas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653099/ https://www.ncbi.nlm.nih.gov/pubmed/36342797 http://dx.doi.org/10.1097/RLU.0000000000004384 |
Ejemplares similares
-
Eligibility for (177)Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of (68)Ga-PSMA-11 and (99m)Tc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
por: Cook, Gary J.R., et al.
Publicado: (2023) -
Tc-99m TRODAT uptake in an osteoid tumor of clivus
por: Taywade, Sameer, et al.
Publicado: (2016) -
Idiopathic Hepatic and Splenic Uptake of (99m)Tc-Methylene Diphosphonate
por: Kalimuthu, Lokeshwaran Madurai, et al.
Publicado: (2020) -
Incidental Tc-99m Methylene Diphosphonate Uptake in an Active Thyroid Nodule
por: Çayır, Derya, et al.
Publicado: (2017) -
Efficacy of focal high-dose-rate brachytherapy in the treatment of patients diagnosed with low or favourable intermediate-risk prostate cancer—a protocol for a randomised controlled trial
por: Jonušas, Justinas, et al.
Publicado: (2023)